Amgen Inc

ISIN US0311621009 Symbol AMGN Industry Drug Manufacturers-General Sector Healthcare
Amgen Price
239.8USD 0.72%
1y Low: 188.9
1y High: 274.6
1y Low: 188.9
1y High: 274.6
Amgen Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
amgen.com
Market Cap
142.2 B USD
Dividend Yield
2.6%
Performance 1y
0.73 %
PER
20.0

Amgen Stock Chart

Amgen Dividend Chart

Amgen Dividend Calendar

Year # Div. Div. Paid Div. Yield Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2021 2 3.52 USD 2.8 %
2020 4 6.40 USD 2.9 %
2019 4 5.80 USD 2.5 %
2018 4 5.28 USD 2.9 %
2017 4 4.60 USD 2.8 %
2016 4 4.00 USD 3.0 %
2015 4 3.16 USD 2.2 %
2014 4 2.44 USD 1.8 %
2013 4 1.88 USD 1.9 %
2012 4 1.44 USD 2.0 %
2011 2 0.56 USD 1.2 %
2010 0 0 USD 0.0 %
2009 0 0 USD 0.0 %
2008 0 0 USD 0.0 %
2007 0 0 USD 0.0 %
2006 0 0 USD 0.0 %
2005 0 0 USD 0.0 %
2004 0 0 USD 0.0 %
2003 0 0 USD 0.0 %
2002 0 0 USD 0.0 %
2001 0 0 USD 0.0 %
2000 0 0 USD 0.0 %
1999 0 0 USD 0.0 %
1998 0 0 USD 0.0 %
1997 1 0.00020 USD 0.0 %

Amgen Performance

1 Week
1 Month
6 Months
2.50 %
Year to Date
5.79 %
1 Year
0.73 %
5 Years
57.82 %

Amgen Revenue, EBIT, and Income

Amgen Margins

Amgen Shares Outstanding

Useful Links

Search Twitter: $AMGN, #AMGN

Amgen Company Info

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, a pegylated protein to treat cancer patients; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Sensipar/Mimpara to treat secondary hyperparathyroidism; and EPOGEN to treat anemia caused by chronic kidney disease. It also markets other products in various markets, including Nplate, Vectibix, Repatha, Parsabiv, BLINCYTO, Aimovig, NEUPOGEN, Otezla, AMGEVITA, KANJINTI, EVENITY, IMLYGIC, MVASI, and Corlanor. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; QIAGEN N.V.; Adaptive Biotechnologies; and Eli Lilly and Company, as well as has a strategic agreement with McKesson Corporation to help improve cancer care in community oncology settings. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

Amgen Price to Earnings Ratio (PE Ratio): 20.0

The current Price to Earnings Ratio of Amgen is 20.0.
The PE Ratio is calcluated by dividing the current Amgen share price (239.8 USD) by the earnings per share (12.3).

Amgen Dividend Yield: 2.6%

The current Dividend Yield of Amgen is 2.6%.

Amgen Market Cap: 142.2 B USD

The current market cap of Amgen is 142.2 B USD.

Amgen Stock Price: 239.8 USD

The current stock price of Amgen is 239.8 USD.

Amgen ISIN: US0311621009

The ISIN (International Securities Identification Number) of Amgen is US0311621009.

Amgen Ticker Symbol: AMGN

The ticker symbol of Amgen is AMGN.

Amgen Address

The address of the Amgen HQ is One Amgen Center Drive, 91320-1799 Thousand Oaks, CA, USA.